Table 5.
FLIS = 6 (n = 49) | FLIS < 6 (n = 49) | P | |
---|---|---|---|
Sex, male, n (%) | 39 (79.6) | 33 (67.3) | 0.252 |
Median age (years) | 71 | 74 | 0.266 |
HBV infection, yes, n (%) | 12 (24.5) | 7 (14.3) | 0.307 |
HCV infection, yes, n (%) | 16 (32.7) | 18 (36.7) | 0.832 |
Number of tumors, median | 1 | 1 | 0.778 |
Solitary, n (%) | 40 (81.6) | 36 (73.5) | 0.468 |
Largest tumor size (cm), median | 40 | 40 | 0.623 |
Largest tumor size, > 3 cm, n (%) | 29 (59.2) | 30 (61.2) | 1.000 |
Serum AFP level (ng/mL), median | 9.5 | 11.8 | 0.183 |
Child–Pugh grade, A, n (%) | 49 (100) | 43 (87.8) | 0.027 |
ALBI grade, I, n (%) | 49 (100) | 46 (93.9) | 0.242 |
Microscopic portal vein invasion, +, n (%) | 16 (32.7) | 14 (28.6) | 0.827 |
Microscopic hepatic vein invasion, +, n (%) | 3 (6.1) | 3 (6.1) | 1.000 |
Microvascular invasion, +, n (%) | 16 (32.7) | 15 (30.6) | 1.000 |
Surgical procedure, minor resection, n (%) | 40 (81.6) | 39 (79.6) | 1.000 |
Anatomic resection, n (%) | 38 (77.6) | 31 (63.3) | 0.184 |
Values represent the number of patients or mean or median values, as indicated.
FLIS, Functional liver imaging score; HBV, Hepatitis B virus; HCV, Hepatitis C virus; AFP, alpha-fetoprotein; ALBI, albumin–bilirubin grade.